BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3883734)

  • 21. Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
    Reifart N; Neidl K; Kaltenbach M; Bussmann WD
    Am Heart J; 1985 Mar; 109(3 Pt 2):708-12. PubMed ID: 3919550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
    Baudry C
    Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
    Korabel'shchikova NI; Rishko NV; Bichko MV
    Vrach Delo; 1985 Aug; (8):19-21. PubMed ID: 3840931
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute double blind trial of a new anti-anginal drug: molsidomine.
    Guerchicoff S; Vazquez A; Kunik H; Drajer S; Díaz F
    Eur J Clin Pharmacol; 1978 Jun; 13(4):247-50. PubMed ID: 352706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the chronic antianginal effect of molsidomine.
    Dalla-Volta S; Scorzelli L; Razzolini R
    Am Heart J; 1985 Mar; 109(3 Pt 2):682-4. PubMed ID: 3883736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention with molsidomine of coronary artery spasm caused by alkalosis.
    Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
    Am Heart J; 1985 Mar; 109(3 Pt 2):704-7. PubMed ID: 3838408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
    Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
    Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molsidomine, an effective long-acting anti-anginal drug.
    Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
    Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 32. Molsidomine in the treatment of acute heart failure.
    Drajer S; Vazquez A; Cercós H; Torres H; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Am Heart J; 1985 Mar; 109(3 Pt 2):712-5. PubMed ID: 3838409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
    Renard M; Jacobs P; Liebens I; Friart A; Bernard R
    Am Heart J; 1985 Mar; 109(3 Pt 2):720-2. PubMed ID: 3919551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimine.
    Stengele E; Ruf G; Jähnchen E; Trenk D; Löffler K; Schulz W; Roskamm H
    Am J Cardiol; 1996 May; 77(11):937-41. PubMed ID: 8644642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
    Sobolski J; Vandermoten P; Stoupel E; Berkenboom G; Degre S
    Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Corvaton in the ambulatory treatment of patients with angina pectoris].
    Bichan NA
    Klin Med (Mosk); 1984 Oct; 62(10):39-40. PubMed ID: 6549037
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.